ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Unicycive Therapeutics Inc

Unicycive Therapeutics Inc (UNCY)

5.29
0.03
( 0.57% )
更新日時: 02:16:59

Unicycive Therapeutics Inc (UNCY) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
5.29
( 0.57% )
買値
5.27
売値
5.29
出来高
734,875
平均取引量 (3 か月)
US$ 1,343,999
財務取引量
US$ 3,820,779
5.0606 日の範囲 5.36
3.71 52 週間の範囲 8.74
時価総額
企業価値
99.22M
前日終値
5.26
始値
5.30
時刻
3
@
5.29
最終取引時間
02:17:48
VWAP
5.1992
歳入
-
純利益
-39.95M
発行済株式数
26,700,027
浮動株比率 (%)
85.70%
機関投資家保有比率 (%)
37.17%
配当利回り
PER
-2.72
株価売上高倍率 (PSR)
-
1 株当たり利益 (EPS)
-1.76
ベータ
1.79

Unicycive Therapeutics Inc について

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosph... Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California. 詳細を表示

セクター
Health Care
業界
-
ウェブサイト
本社
Mountain View, United States
設立
2026
Unicycive Therapeutics Inc is listed in the Health Care sector of the ナスダック市場 with ticker UNCY. The last closing price for Unicycive Therapeutics was US$5.26. Over the last year, Unicycive Therapeutics shares have traded in a share price range of US$ 3.71 to US$ 8.74.

Unicycive Therapeutics currently has 26,700,027 shares in issue. The market capitalisation of Unicycive Therapeutics is US$141.24 million. Unicycive Therapeutics has a price to earnings ratio (PE ratio) of -2.72.

UNCY 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.52-8.950086058525.815.935.0117203565.38449212CS
4-2.4-31.20936280887.698.563.9332398875.94204281CS
12-1.76-24.96453900717.058.743.9314874816.44378763CS
26-0.89-14.40129449846.188.743.939919746.50034599CS
52-0.26-4.684684684685.558.743.717133235.9689456CS
1564.05326.6129032261.248.740.20210087151.99421009CS
260-3.26-38.12865497088.558.740.2029874572.00511734CS

UNCY - Frequently Asked Questions (FAQ)

What is the current Unicycive Therapeutics Inc share price?
The current share price of Unicycive Therapeutics Inc is US$ 5.29
How many Unicycive Therapeutics Inc shares are in issue?
Unicycive Therapeutics Inc has 26,700,027 shares in issue
What is the market cap of Unicycive Therapeutics Inc?
The market capitalisation of Unicycive Therapeutics Inc is USD 141.24M
What is the 1 year trading range for Unicycive Therapeutics Inc share price?
Unicycive Therapeutics Inc has traded in the range of US$ 3.71 to US$ 8.74 during the past year
What is the PE ratio of Unicycive Therapeutics Inc?
The price to earnings ratio of Unicycive Therapeutics Inc is -2.72
What is the registered address of Unicycive Therapeutics Inc?
The registered address for Unicycive Therapeutics Inc is 1975 West El Camino Real, Mountain View, California, 94040
What is the Unicycive Therapeutics Inc website address?
The website address for Unicycive Therapeutics Inc is unicycive.com

UNCY 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

UNCY Discussion

投稿を表示